Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02938923 · ClinicalTrials.gov registry record · Phase 3

Starting a Testosterone and Exercise Program After Hip Injury

A Phase 3 study, sponsored by Washington University School of Medicine.

Completed
Registry status
Phase 3
Development phase
129
Enrollment target

NCT02938923 is a Phase 3 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 129 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02938923, a Phase 3 study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
Phase 3
Development phase
129 participants
Enrollment target

Study Summary

This study is a randomized controlled double-blinded multi-center clinical trial enrolling female hip fracture patients who are 65 and older. It will compare the effects of six months of supervised exercise training combined with daily topical testosterone gel, to six months of supervised exercise and inactive gel, and to Enhanced Usual Care. The randomization protocol is that for every nine participants randomized, 4 will be assigned to the topical testosterone gel and supervised exercise training group; 4 will be assigned to topical inactive gel and supervised exercise training group; and 1 will be assigned to the enhanced usual care group. All participants will receive nutritional counseling, and calcium and vitamin D supplements.

Interventions

  • DRUG Testosterone
  • DRUG Placebo gel
  • BEHAVIORAL Home exercise program
  • BEHAVIORAL Supervised exercise training
  • BEHAVIORAL Health Education Modules

Trial Details

FieldValue
Enrollment Target 129 participants
Start Date 2019-03-05
Est. Completion 2023-11-06
Phase Phase 3

What the Registry Record Tells You About NCT02938923

The ClinicalTrials.gov registry entry for NCT02938923 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Testosterone is the first listed.

NCT02938923 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02938923 about?

NCT02938923 is a clinical study titled "Starting a Testosterone and Exercise Program After Hip Injury". This study is a randomized controlled double-blinded multi-center clinical trial enrolling female hip fracture patients who are 65 and older. It will compare the effects of six months of supervised exercise training combined with daily topical testosterone gel, to six months of supervised exercise a...

What is the current status of trial NCT02938923?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 129 participants. The study started on 2019-03-05. Estimated completion is 2023-11-06.

What interventions are being tested in trial NCT02938923?

The interventions under investigation include: Testosterone (DRUG), Placebo gel (DRUG), Home exercise program (BEHAVIORAL), Supervised exercise training (BEHAVIORAL), Health Education Modules (BEHAVIORAL).

Who is sponsoring clinical trial NCT02938923?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.